Mechanism of hypertriglyceridemia in CTP: Phosphoethanolamine cytidylyltransferase-deficient mice

Journal of Lipid Research

Volumn 53, Issue 9, 2012, Pages 1811-1822

  Singh, Ratnesh Kumar ^a   Fullerton, Morgan D ^a   Vine, Donna ^b   Bakovic, Marica ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chylomicron formation; Phospholipid; Triglyceride; Very low density lipoprotein secretion

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 4; APOLIPOPROTEIN B100; CHYLOMICRON; CYTIDINE TRIPHOSPHATE; ETHANOLAMINE PHOSPHATE CYTIDYLYLTRANSFERASE; LIPOPROTEIN LIPASE; TRANSFERASE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD46 GENE; CONTROLLED STUDY; DGAT1 GENE; DGAT2 GENE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FAS GENE; FATP4 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HETEROZYGOTE; HYPERTRIGLYCERIDEMIA; INTESTINE SECRETION; LIPID ABSORPTION; LIPID METABOLISM; LIPID TRANSPORT; LIPOPROTEIN SECRETION; LIVER CLEARANCE; LIVER MICROSOME; MGAT2 GENE; MOUSE; MTP GENE; NONHUMAN; PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE DEFICIENCY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SREBP1 GENE; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UPREGULATION;

ANGIOPOIETINS; ANIMALS; APOLIPOPROTEINS B; CARRIER PROTEINS; CHYLOMICRONS; FATTY ACIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; HYPERTRIGLYCERIDEMIA; INTESTINAL ABSORPTION; INTESTINES; LIPASE; LIPOPROTEIN LIPASE; LIVER; MICE; POSTPRANDIAL PERIOD; RNA NUCLEOTIDYLTRANSFERASES; TRIGLYCERIDES;

EID: 84864829883     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M021881     Document Type: Article

References (46)

1. Guo, Y., T. C. Walther, M. Rao, N. Stuurman, G. Goshima, K. Terayama, J. S. Wong, R. D. Vale, P. Walter, and R. V. Farese. 2008. Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature. 453: 657-661. (Pubitemid 351769298)
2. Igal, R. A., J. M. Caviglia, I. N. De Gomez Dumm, and R. A. Coleman. 2001. Diacylglycerol generated in CHO cell plasma membrane by phospholipase C is used for triacylglycerol synthesis. J. Lipid Res. 42: 88-95. (Pubitemid 32142863)
3. Caviglia, J. M., I. N. De Gomez Dumm, R. A. Coleman, and R. A. Igal. 2004. Phosphatidylcholine deficiency upregulates enzymes of triacylglycerol metabolism in CHO cells. J. Lipid Res. 45: 1500-1509. (Pubitemid 39006978)
4. Vance, D. E. 2008. Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr. Opin. Lipidol. 19: 229-234. (Pubitemid 351653559)
5. Vance, D. E., and J. E. Vance. 2009. Physiological consequences of disruption of mammalian phospholipid biosynthetic genes. J. Lipid Res. 50 (Suppl.): S132-137.
6. Li, Z., L. B. Agellon, T. M. Allen, M. Umeda, L. Jewell, A. Mason, and D. E. Vance. 2006. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 3: 321-331.
7. Fu, S., L. Yang, P. Li, O. Hofmann, L. Dicker, W. Hide, X. Lin, S. M. Watkins, A. R. Ivanov, and G. S. Hotamisligil. 2011. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature. 473: 528-531.
8. Fullerton, M. D., F. Hakimuddin, and M. Bakovic. 2007. Developmental and metabolic effects of disruption of the mouse CTP: phosphoethanolamine cytidylyltransferase gene (Pcyt2). Mol. Cell. Biol. 27: 3327-3336. (Pubitemid 46685211)
9. Bakovic, M., M. D. Fullerton, and V. Michel. 2007. Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2). Biochem. Cell Biol. 85: 283-300. (Pubitemid 47025908)
10. Hermansson, M., K. Hokynar, and P. Somerharju. 2011. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog. Lipid Res. 50: 240-257.
11. Poloumienko, A., A. Cote, A. Q. Tie, L. Zhu, and M. Bakovic. 2004. Genomic organization and differential splicing of the mouse and human Pcyt2 genes. Gene. 325: 145-155. (Pubitemid 38030385)
12. Tie, A., and M. Bakovic. 2007. Alternative splicing of CTP: phosphoethanolamine cytidylyltransferase produces two isoforms that differ in catalytic properties. J. Lipid Res. 48: 2172-2181. (Pubitemid 47529560)
13. Johnson, C. M., Z. Yuan, and M. Bakovic. 2005. Characterization of transcription factors and cis-acting elements that regulate human CTP:phosphoethanolamine cytidylyltransferase (Pcyt2). Biochim. Biophys. Acta. 1735: 230-235. (Pubitemid 41140433)
14. Zhu, L., V. Michel, and M. Bakovic. 2009. Regulation of the mouse CTP:phosphoethanolamine cytidylyltransferase gene Pcyt2 during myogenesis. Gene. 447: 51-59.
15. Zhu, L., and M. Bakovic. 2008. Liver X receptor agonists inhibit the phospholipid regulatory gene CTP:phosphoethanolamine cytidylyltransferase-Pcyt2. Biochem. Res. Int. 2008: 801849.
16. Fullerton, M. D., F. Hakimuddin, A. Bonen, and M. Bakovic. 2009. The development of a metabolic disease phenotype in CTP: phosphoethanolamine cytidylyltransferase deficient mice. J. Biol. Chem. 284: 25704-25713.
17. Fullerton, M., and M. Bakovic. 2010. Complementation of the metabolic defect in CTP: phosphoethanolamine cytidylyltransferase (Pcyt2) deficient primary hepatocites. Metabolism. 59: 1691-1700.
18. Leonardi, R., M. W. Frank, P. D. Jackson, C. O. Rock, and S. Jackowski. 2009. Elimination of the CDP-ethanolamine pathway disrupts hepatic lipid homeostasis. J. Biol. Chem. 284: 27077-27089.
19. Millar, J. S., D. A. Cromley, M. G. McCoy, D. J. Rader, and J. T. Billheimer. 2005. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J. Lipid Res. 46: 2023-2028. (Pubitemid 41248500)
20. Johnston, T. P. 2010. Poloxamer 407 as a general lipase inhibitor: its implication in lipid metabolism and atheroma formation in C57BL/6 mice. J. Pharm. Pharmacol. 62: 1807-1812.
21. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Med. Sci. 37: 911-917.
22. Goudriaan, J. R., S. M. S. E. Santo, P. J. Voshol, and P. C. Rensen. 2004. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45: 1475-1481. (Pubitemid 39006975)
23. Moen, C. J., A. P. Tholens, P. J. Voshol, and P. C. Rensen. 2007. The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglycerides. J. Lipid Res. 48: 2182-2192. (Pubitemid 47529561)
24. Vine, D. F., R. Takechi, J. C. Russell, and S. D. Proctor. 2007. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis. 190: 282-290. (Pubitemid 46074043)
25. Swift, L. L., A. Jovanovska, B. Kakkad, and D. E. Ong. 2005. Microsomal triglyceride transfer protein expression in mouse intestine. Histochem. Cell Biol. 123: 475-482. (Pubitemid 40922230)
26. Cheng, D., J. Iqbal, J. Devenny, C-H. Chu, L. Chen, J. Dong, R. Seethala, W. J. Keim, A. V. Azzara, R. M. L. Lawrence, et al. 2008. Acylation of acylglycerols by acyl coenzyme A:diacylglycerol acyltransferase 1 (DGAT1). Functional importance of DGAT1 in the intestinal fat absorption. J. Biol. Chem. 283: 29802-29811.
27. Luchoomun, J., and M. M. Hussain. 1999. Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J. Biol. Chem. 274: 19565-19572.
28. Nayak, N., E. H. Harrison, and M. M. Hussain. 2001. Retinyl ester secretion by intestinal cells: a specific and regulated process dependent on assembly and secretion of chylomicrons. J. Lipid Res. 42: 272-280. (Pubitemid 32206840)
29. Anwar, K., H. J. Kayden, and M. M. Hussain. 2006. Transport of vitamin E by differentiated Caco-2 cells. J. Lipid Res. 47: 1261-1273. (Pubitemid 43830718)
30. Iqbal, J., and M. M. Hussain. 2005. Evidence for multiple complementary pathways for efficient cholesterol absorption in mice. J. Lipid Res. 46: 1491-1501. (Pubitemid 43109814)
31. Lu, B., A. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 2010. The acute phase response stimulates the expression of angiopietin like proten 4. Biochem. Biophys. Res. Commun. 391: 1737-1741.
32. Yen, C. L., S. J. Stone, S. Koliwad, C. Harris, and R. V. Farese, Jr. 2008. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 49: 2283-2301.
33. Hsieh, J., C. Longuet, A. Maida, J. Bahrami, E. Xu, C. L. Baker, and K. Adeli. 2009. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology. 137: 997-1005.
34. De Guzman, J. M., G. Ku, R. Fahey, Y. H. Youm, I. Kass, D. K. Ingram, V. D. Dixit, and I. Kheterpal. Chronic caloric restriction partially protects against age-related alteration in serum metabolome. Age (Dordr.). Epub ahead of print. June 4, 2012. DOI 10.1007/s11357-012-9430-x.
35. Sample, J., J. G. Cleland, and A. M. Seymour. 2006. Metabolic remodeling in the aging heart. J. Mol. Cell. Cardiol. 40: 56-63. (Pubitemid 43012117)
36. Ming, X. F., J. P. Montani, and Z. Yang. 2012. Perspectives of Targeting mTORC1-S6K1 in cardiovascular aging. Front Physiol. 3: 5-11.
37. Kapahi, P., D. Chen, A. N. Rogers, S. D. Katewa, P. W. Li, E. L. Thomas, and L. Kockel. 2010. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab. 11: 453-465.
38. Lichtenstein, L., and S. Kersten. 2010. Modulation of plasma TG lipolysis by angiopoietin-like proteins and GPIHBP1. Biochim. Biophys. Acta. 1801: 415-420.
39. Dallinga-Thie, G. M., R. Franssen, H. L. Mooij, M. E. Visser, H. C. Hassing, F. Peelman, J. J. Kastelein, M. Péterfy, and M. Nieuwdorp. 2010. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis. 211: 1-8.
40. Davies, B. S., A. P. Beigneux, L. G. Fong, and S. G. Young. 2012. New wrinkles in lipoprotein lipase biology. Curr. Opin. Lipidol. 23: 35-42.
41. Chatterjee, C., and D. L. Sparks. 2011. Hepatic lipase, high density lipoproteins, and hypertriglyceridemia. Am. J. Pathol. 178: 1429-1433.
42. Pratt, S. M., S. Chiu, G. M. Espinal, N. M. Shibata, H. Wong, and C. H. Warden. 2010. Mouse hepatic lipase alleles with variable effects on lipoprotein composition and size. J. Lipid Res. 51: 1035-1048.
43. Hsieh, J., A. A. Hayashi, J. Webb, and K. Adeli. 2008. Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity. Atheroscler. Suppl. 9: 7-13.
44. Cortón, M., J. I. Botella-Carretero, A. Benguría, A. Villuendas Zaballos, J. L. San Millán, H. F. Escobar-Morreale, and B. Peral. 2007. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92: 328-337. (Pubitemid 46075011)
45. Frederiksen, C. M., K. Højlund, L. Hansen, E. J. Oakeley, B. Hemmings, B. M. Abdallah, K. Brusgaard, H. Beck-Nielsen, and M. Gaster. 2008. Transcriptional profiling of myotubes from patients with type-2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia. 51: 2068-2077.
46. Lee, Y. H., S. Nair, E. Rousseau, D. B. Allison, G. P. Page, P. A. Tataranni, C. Bogardus, and P. A. Permana. 2005. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia. 48: 1776-1783. (Pubitemid 41317831)